Cancer immunology & Immunotherapy

Scott Atwood
Scott X. Atwood, Ph.D.
Associate Professor, Developmental & Cell Biology
carcinoma, immunity
Angela Fleischman
Angela Fleischman, M.D., Ph.D.
Associate Professor of Medicine, Division of Hematology/Oncology
myeloproliferative neoplasm, calreticulin
David Fruman
David Fruman, Ph.D.
Professor of Molecular Biology and Biochemistry, Acting Director of the Cancer Research Institute and Director of the GPS-STEM program.
signal transduction in lymphocytes and leukemia cells
Anand Ganesan
Anand K. Ganesan, M.D., Ph.D.
Professor in the Department of Dermatology and Department of Biological Chemistry
host response to melanoma
Chris Halbrook
Christopher J. Halbrook, Ph.D.
Assistant Professor, Molecular Biology and Biochemistry
immune responses in pancreatic cancer
Kai Kessenbrock
Kai Kessenbrock, Ph.D.
Assistant Professor, Department of Biological Chemistry.
immune responses in breast cancer, transcriptomics
Devon Lawson
Devon A Lawson, Ph.D.
Associate Professor, Physiology & Biophysics
immune responses in breast cancer metastases to the brain
Francesco Marangoni
Francesco Marangoni, Ph.D.
Assistant Professor, Physiology and Biophysics
cancer immunotherapy, T regs, intravital microscopy
Ed Nelson
Edward Nelson, M.D.
Professor of Medicine and Molecular Biology and Biochemistry; Chief of the Division of Hematology/Oncology.
cancer immunotherapy, dendritic cells
Nick Pannunzio
Nick Pannunzio, Ph.D.
Assistant Professor, Medicine, Division of Hematology/Oncology
B cell class switching in lymphoid neoplasms
Roberto Tinoco
Roberto Tinoco, Ph.D.
Assistant Professor of Molecular Biology and Biochemistry
chronic viral infection, cancer immunotherapy
Marian Waterman
Marian Waterman, Ph.D.
Professor of Microbiology & Molecular Genetics, and Deputy Director of the Chao Family Comprehensive Cancer Center
Wnt signaling in colon cancer

Scroll to Top